The Prepacked Chromatography Columns Market has witnessed substantial growth due to the increasing demand for biologics, including monoclonal antibodies, vaccines, and gene therapies. These ...

Y-Biologics, an emerging biotechnology company ... and they can be easily purified from there with traditional affinity chromatography—the quality control is highly regulated,” said Bum ...

These therapeutics are manufactured in cells, so they run the risk of containing product- and process-related impurities that may affect a drug’s safety profile. Scientists purify these biologics ...

Unfortunately, these next-generation biologics (NGBs), such as fusion proteins, exhibit additional levels of complexity beyond regular monoclonal antibody therapeutics. New methods, techniques and ...

chromatography resins are prominent pieces in the chain of purification for these essential, life-saving angels in today's bio-pharma sector. Biologics are in high demand worldwide due to rising ...

The chromatography resin market is benefiting from various growth opportunities, particularly in the pharmaceutical and biotechnology sectors. The increasing investment in biologics, biosimilars ...

As drug development accelerates, especially in biologics and biosimilars, advanced downstream processing techniques are essential for ensuring product quality and yield. The market is benefitting from ...

This novel affinity chromatography offering marries Repligen’s breakthrough dsRNA purification resin with its flagship OPUS pre-packed columns. The AVIPure dsRNA Clear resin offers unmatched ...